WMT

124.38

-1.32%↓

COST

986.4

-0.53%↓

PG

163.47

-0.41%↓

KO

80.59

+0.26%↑

PM

189.59

-0.25%↓

WMT

124.38

-1.32%↓

COST

986.4

-0.53%↓

PG

163.47

-0.41%↓

KO

80.59

+0.26%↑

PM

189.59

-0.25%↓

WMT

124.38

-1.32%↓

COST

986.4

-0.53%↓

PG

163.47

-0.41%↓

KO

80.59

+0.26%↑

PM

189.59

-0.25%↓

WMT

124.38

-1.32%↓

COST

986.4

-0.53%↓

PG

163.47

-0.41%↓

KO

80.59

+0.26%↑

PM

189.59

-0.25%↓

WMT

124.38

-1.32%↓

COST

986.4

-0.53%↓

PG

163.47

-0.41%↓

KO

80.59

+0.26%↑

PM

189.59

-0.25%↓

Search

Beauty Health Co

Abrir

0.95 4.4

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.87

Máximo

0.96

Indicadores-chave

By Trading Economics

Rendimento

-31M

-11M

Vendas

-7.5M

71M

Margem de lucro

-15.612

Funcionários

769

EBITDA

-24M

4.1M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+83.15% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-57M

116M

Abertura anterior

-3.45

Fecho anterior

0.95

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Beauty Health Co Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de fev. de 2026, 23:25 UTC

Ações em Alta

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25 de fev. de 2026, 23:15 UTC

Ganhos

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25 de fev. de 2026, 23:54 UTC

Conversa de Mercado

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25 de fev. de 2026, 23:47 UTC

Ganhos

Ferrovial 4Q Net EUR197M >FER.MC

25 de fev. de 2026, 23:45 UTC

Ganhos

Ferrovial 4Q Rev EUR2.72B >FER.MC

25 de fev. de 2026, 23:42 UTC

Ganhos

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25 de fev. de 2026, 23:38 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com: Company's Business Operations Remain Normal >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25 de fev. de 2026, 23:25 UTC

Ganhos

Trip.com FY EPS CNY47.67 >TCOM

25 de fev. de 2026, 23:06 UTC

Ganhos

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25 de fev. de 2026, 23:01 UTC

Ganhos

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25 de fev. de 2026, 23:00 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

25 de fev. de 2026, 23:00 UTC

Conversa de Mercado
Ganhos

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25 de fev. de 2026, 22:56 UTC

Conversa de Mercado
Ganhos

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25 de fev. de 2026, 22:43 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25 de fev. de 2026, 22:40 UTC

Conversa de Mercado
Ganhos

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25 de fev. de 2026, 22:40 UTC

Ganhos

Karoon Energy Says Search for New CFO Well Advanced

25 de fev. de 2026, 22:39 UTC

Ganhos

Karoon Energy Says CFO Ray Church to Leave Company

25 de fev. de 2026, 22:39 UTC

Ganhos

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25 de fev. de 2026, 22:38 UTC

Ganhos

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Comparação entre Pares

Variação de preço

Beauty Health Co Previsão

Preço-alvo

By TipRanks

83.15% parte superior

Previsão para 12 meses

Média 1.63 USD  83.15%

Máximo 1.65 USD

Mínimo 1.6 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Beauty Health Co - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.05 / 1.42Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

No Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Beauty Health Co

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
help-icon Live chat